← Leaderboards
Shaoling Huang
University Of Texas Hlth Sci Ctr Houston
$1,930,601
Attributed
$4,169,579
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2010–25$2M$1.5M$1M$500K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,169,579 · 3
By mechanism
R42$3,536,579 · 1
R21$408,000 · 1
R41$225,000 · 1
Top collaborators
- Keith Booher5 shared
- Wei Guo3 shared
Most similar at University Of Texas Hlth Sci Ctr Houston
Same institution · by research overlap
- Jaroslaw A. Aronowski$13,611,686
- Joan M Bull$523,420
- John B Holcomb$3,386,224
- Sunil Sheth$2,405,480
- Xuefang Sophie Ren$6,180,221
Others in their field
Top investigators on “Liposomes”
- Katherine W Ferrara · Stanford University$21,313,923
- James C. Paulson · Scripps Research Institute$15,907,257
- David D McPherson · Northwestern University$13,361,624
- Michael B Zwick · Scripps Research Institute, The$13,172,478
- Gary Fujii · Molecular Express, Inc.$12,568,015
- Casey Koontz · Leidos, Inc.$11,293,734
Research focus
LiposomesIschemic StrokeXenonStrokeInjuryAnimalsTexasDiffusionTherapeutic EffectPathologicHealth SciencesSmall Business Technology Transfer ResearchEpigenetic ProcessEpigenetic MarkerPreventNeurologic DysfunctionsBiological MarkersAcuteBrainBlood - Brain Barrier AnatomyCytoprotectionGasesNeuroprotectionProtocols Documentation
Grant awards (7)
A Novel Xenon Delivery Platform for Cerebroprotection During Stroke$980,725
R42 · FY2025 · NS
A Novel Xenon Delivery Platform for Cerebroprotection During Stroke$631,721
R42 · FY2024 · NS
Epigenetic Markers and Sustained Cytoprotection for Stroke Treatment$841,419
R42 · FY2022 · NS
Epigenetic Markers and Sustained Cytoprotection for Stroke Treatment$1,082,714
R42 · FY2021 · NS
Epigenetic Markers and Sustained Cytoprotection for Stroke Treatment$225,000
R41 · FY2017 · NS
Novel Strategy Development for Neuroprotective Therapeutics Delivery in Stroke$220,500
R21 · FY2011 · NS · contact PI
Novel Strategy Development for Neuroprotective Therapeutics Delivery in Stroke$187,500
R21 · FY2010 · NS · contact PI